Hubei University of Chinese Medicine.
Hubei Provincial Hospital of Chinese Medicine.
Medicine (Baltimore). 2021 Jan 8;100(1):e24121. doi: 10.1097/MD.0000000000024121.
Allergic rhinitis (AR) is one of the most common chronic disease of the nasal mucosa globally. Several clinical studies have shown that sanfu acupoint herbal patching (SAHP) has obvious advantages in treating AR. Therefore, the purpose of this systematic review is to evaluate the effectiveness and safety of SAHP for treating AR.
The following 9 electronic databases will be searched from January 2010 to October 2020: PubMed/Medline, Web of Science, Cochrane Library, EMBASE, China National Knowledge Infrastructure, VIP Database, WANFANG Database, China Biology Medicine disc. The selection of the studies and the extraction of the data are independently completed by 2 reviewers. The qualities of the studies are evaluated by Cochrane risk-of-bias tool. The main outcome of included studies is total effective rate. Secondary outcomes are Total Nasal Symptom Score, recurrence rate, Rhinitis Quality of Life Questionnaire, adverse events and laboratory indicators: serum immunoglobulin E (IgE). And the STATA 14.0 software will be implemented for data synthesis and meta-analysis.
The review is ongoing, no results can be reported.
The systematic review will provide a better option for patients to treat AR.
INPLASY2020100101.
变应性鼻炎（AR）是全球最常见的鼻腔黏膜慢性疾病之一。多项临床研究表明，三伏穴位敷贴（SAHP）在治疗 AR 方面具有明显优势。因此，本系统评价旨在评估 SAHP 治疗 AR 的有效性和安全性。
从 2010 年 1 月至 2020 年 10 月，我们将检索以下 9 个电子数据库：PubMed/Medline、Web of Science、Cochrane Library、EMBASE、中国知网、维普数据库、万方数据库、中国生物医学文献数据库。由 2 位评价者独立完成研究选择和数据提取。使用 Cochrane 偏倚风险工具评估研究质量。主要结局指标为总有效率。次要结局指标为总鼻症状评分、复发率、鼻炎生活质量问卷、不良反应和实验室指标：血清免疫球蛋白 E（IgE）。将使用 STATA 14.0 软件进行数据分析和荟萃分析。
本综述正在进行中，目前尚无结果可报告。
本系统评价将为患者治疗 AR 提供更好的选择。
INPLASY2020100101。
